Infographic: 2027 Medicare Part D Changes
Home
2027 Medicare Prescription Payment Plan
Medicare Part D prescription drug plans will have an out-of-pocket maximum of $2,400 for 2027 and beneficiaries can also opt in to the Medicare Prescription Payment Plan (MPPP)—a program that lets you pay for prescriptions in monthly installments. The MAPRx Coalition has created this patient guide with more information. 2027 Medicare Prescription Payment Plan
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2026 – December 7, 2026 for coverage beginning January 1, 2076. Plans make changes to benefits and costs, and there are also many new changes for the 2027 plan year.
MAPRx encourages both new and existing beneficiaries to use this time period to... Read more
THE MEDICARE GLP-1 BRIDGE
In December 2025, the Centers for Medicare & Medicaid Services (CMS) announced two major initiatives to expand access to obesity management medications for Medicare and Medicaid beneficiaries: the Medicare GLP-1 Bridge program and the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) Model. CMS has announced an indefinite delay of the BALANCE Model’s Medicare Part D component due... Read more
Inflation Reduction Act: Access Barriers Undermine Affordability
Enacted in 2022, the Inflation Reduction Act (IRA) introduced significant reforms aimed at reducing the financial burden of prescription drug costs for Medicare Part D beneficiaries.
A new report from MAPRx, however, shows that as a larger share of liability has shifted from the federal government to plans and pharmaceutical manufacturers, plan behavior is seen changing... Read more
Comments on the Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
The MAPRx coalition has championed policies in Part D that improve the affordability of medications and beneficiary access to those medications, including provisions of the Inflation Reduction Act (IRA) that establish an out-of-pocket cap in Part D and the Medicare Prescription Payment Plan. MAPRx strongly opposes the GUARD Model and urges CMS to abandon this proposal and withdraw the model.... Read more